U.S. Blood Collection Market To Reach $2.08 Billion By 2030

U.S. Blood Collection Market Growth & Trends

The U.S. blood collection market size is expected to reach USD 2.08 billion by 2030, according to a new study by Grand View Research, Inc. The market is projected to grow at a CAGR of 8.91% from 2025 to 2030. The increasing prevalence of chronic and infectious diseases, growing number of blood transfusions, and rising prevalence of hematological disorders are primarily driving the overall market growth. As per CDC data, approximately 38 million adults were suffering from diabetes in 2022. In addition, obesity is linked to up to 53% of new type 2 diabetes cases annually. Thus, the increasing prevalence of diabetes is expected to boost the demand for vacutainers in recurring diagnostic tests, such as blood sugar assays.

The growing prevalence of hematological disorders highlights the need for vacutainers to diagnose these disorders, driving the demand for vacuum blood collection devices. For instance, the Leukemia & Lymphoma Society reports that approximately one person is diagnosed with blood cancer every 3 minutes. This increasing burden of hematological disorders necessitates effective blood collection methods for diagnosis and monitoring, thereby propelling the blood collection market.

The growing advancements in technology have made the blood collection market more sophisticated and accurate. Moreover, expansion of Point-of-Care Testing (POCT) solutions in various healthcare settings, including pharmacies, urgent care centers, and clinics, can drive the demand for blood collection in the U.S. Community pharmacies are increasingly playing a pivotal role in collection services, leveraging their accessibility and patient trust to enhance healthcare delivery. Thus, community pharmacies are expanding their role in POCT, offering convenient and accessible diagnostic services, including blood collection, directly to patients in the U.S.

 Request a free sample copy or view report summary: U.S. Blood Collection Market Report

U.S. Blood Collection Market Report Highlights

• Based on site, the venous segment dominated the market with a revenue share of 82.44%. owing to its reliability and efficiency in obtaining high-quality samples.

• Based on end use, the hospitals segment dominated the market with a revenue share of 28.01%, owing to the high number of cases and diagnostic tests being conducted.

• Based on age, the 19 to 65 segments accounted for the largest market share in 2024 and are expected to grow at the fastest CAGR over the forecast period

• The urban segment dominated the U.S. market in 2024 and is expected to grow at the fastest CAGR over the forecast period

U.S. Blood Collection Market Segmentation

Grand View Research has segmented the U.S. blood collection market report based on site, application, end use, age, demography, and states.

U.S. Blood Collection Site Outlook (Volume, Units in Million; Revenue, USD Million, 2018 - 2030)

• Venous

  • Needles and Syringes

    • Double-Ended Needles

    • Winged Blood Collection Sets

    • Standard Hypodermic Needles

    • Other Blood Collection Needles

  • Blood Collection Tubes

    • Serum-separating

    • EDTA

    • Heparin

    • Plasma-separating

  • Blood Bags

  • Others

• Capillary

  • Lancets

  • Micro-Container Tubes

  • Micro-Hematocrit Tubes

  • Warming Devices

  • Others

U.S. Blood Collection Application Outlook (Volume, Units in Million; Revenue, USD Million, 2018 - 2030)

• Diagnostics

• Treatment

U.S. Blood Collection End Use Outlook (Volume, Units in Million; Revenue, USD Million, 2018 - 2030)

• Hospitals

• Clinical Laboratories

• Blood Banks Centers

• Clinics

• Mobile Service

• Emergency Departments

• Others

U.S. Blood Collection Age Outlook (Volume, Units in Million; Revenue, USD Million, 2018 - 2030)

• 0-18

• 19 to 65

• 66 years and above

U.S. Blood Collection Demography Outlook (Volume, Units in Million; Revenue, USD Million, 2018 - 2030)

• Urban

• Rural

U.S. Blood Collection States Outlook (Volume, Units in Million; Revenue, USD Million, 2018 - 2030)

• California

• Texas

• Florida

• New York

• Pennsylvania

• Illinois

• Ohio

• Georgia

• North Carolina

• South Carolina

• Michigan

• Alabama

• Arkansas

• Kentucky

• Louisiana

• Mississippi

• Tennessee

• West Virginia

• Virginia

• Colorado

• Alaska

• Vermont

• South Dakota

• Maine

• Oregon

• Rest of U.S.

List of Key Players of U.S. Blood Collection Market

• Sekisui Medical Co., Ltd.

• Becton, Dickinson and Company (BD)

• Greiner Bio-One

• QIAGEN

• Nipro Corporation

• Terumo Corporation

• Haemonetics Corp.

• Zhejiang Gongdong Medical Technology Co., Ltd

• Drucker Diagnostics

• AdvaCare Pharma